Literature DB >> 21979251

Chimeric advanced drug delivery nano systems (chi-aDDnSs) for shikonin combining dendritic and liposomal technology.

Konstantinos N Kontogiannopoulos1, Andreana N Assimopoulou, Sophia Hatziantoniou, Kostas Karatasos, Costas Demetzos, Vassilios P Papageorgiou.   

Abstract

The interest of drug delivery has focused on the creation of new formulations with improved properties, taking much attention to the drug release from the carrier. Liposomes have already been commercialized, while dendrimers and hyperbranched polymers are emerging as potentially ideal drug delivery vehicles. Chimeric advanced drug delivery nano systems (chi-aDDnSs) are mixed nanosystems combining different biomaterials that can offer advantages as drug carriers. Alkannin and shikonin (A/S) are naturally occurring hydroxynaphthoquinones with a well-established spectrum of wound healing, antimicrobial, anti-inflammatory, antioxidant and recently established antitumor activity. In this work three generations of hyperbranched aliphatic polyesters were used for the first time to form complexes with shikonin, as well as liposomal chi-aDDnSs. Characterization of the shikonin-loaded chi-aDDnSs was performed by measuring their particle size distribution, ζ-potential, drug encapsulation efficiency and the in vitro release profile. The analysis revealed sufficient drug encapsulation and appropriately featured release profiles. Chi-aDDnSs were also examined for their physical stability at 4°C. The results are considered promising and could be used as a road map for designing in vivo experiments.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21979251     DOI: 10.1016/j.ijpharm.2011.09.031

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  6 in total

1.  Oral absorption enhancement of probucol by PEGylated G5 PAMAM dendrimer modified nanoliposomes.

Authors:  Qian Ma; Yingchun Han; Cong Chen; Yini Cao; Siling Wang; Wenwen Shen; Huayu Zhang; Yanzhi Li; Mallory A van Dongen; Bing He; Maomao Yu; Lu Xu; Mark M Banaszak Holl; George Liu; Qiang Zhang; Rong Qi
Journal:  Mol Pharm       Date:  2015-01-27       Impact factor: 4.939

2.  Encapsulation of acetylshikonin by polyamidoamine dendrimers for preparing prominent nanoparticles.

Authors:  Jianqing Peng; Wen Zhou; Xinyi Xia; Xiaole Qi; Luan Sun; Min Wang; Zhenghong Wu; Zhengrong Li
Journal:  AAPS PharmSciTech       Date:  2014-01-22       Impact factor: 3.246

Review 3.  Vesicular Nanocarriers for Phytocompounds in Wound Care: Preparation and Characterization.

Authors:  Diana Antonia Safta; Cătălina Bogdan; Mirela Liliana Moldovan
Journal:  Pharmaceutics       Date:  2022-05-05       Impact factor: 6.525

4.  The apoptotic effect of shikonin on human papillary thyroid carcinoma cells through mitochondrial pathway.

Authors:  Chibo Liu; Lihui Yin; Jiaqi Chen; Jiayu Chen
Journal:  Tumour Biol       Date:  2013-10-02

Review 5.  Targeting Glucose Metabolism Enzymes in Cancer Treatment: Current and Emerging Strategies.

Authors:  Yi Zhang; Qiong Li; Zhao Huang; Bowen Li; Edouard C Nice; Canhua Huang; Liuya Wei; Bingwen Zou
Journal:  Cancers (Basel)       Date:  2022-09-21       Impact factor: 6.575

6.  Preparation, cellular uptake and angiogenic suppression of shikonin-containing liposomes in vitro and in vivo.

Authors:  Hongmei Xia; Chengyi Tang; Heng Gui; Xiaoming Wang; Jinliang Qi; Xiuqiang Wang; Yonghua Yang
Journal:  Biosci Rep       Date:  2013-02-01       Impact factor: 3.840

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.